Showing results (181-190 of 293) with videos related to

Sort By:
Pageof 30
Frontiers in Oncology|May 25, 2026
A case report of acute carcinoid heart failure during lutetium-177 dotatate-triapine treatment for well-differentiated neuroendocrine tumorsAman Chauhan, Elise C Kohn, S Percy Ivy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 2, 2015
Toxicity Attribution in Phase I Trials: Evaluating the Effect of Dose on the Frequency of Related and Unrelated ToxicitiesAnne Eaton, Alexia Iasonos, Mrinal M Gounder, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2007
Evaluation of plasma insulin-like growth factor binding protein 2 and Her-2 extracellular domain as biomarkers for 17-allylamino-17-demethoxygeldanamycin treatment of adult patients with advanced solid tumorsJulie L Eiseman, Jianxia Guo, Ramesh K Ramanathan, et al.
Journal of Human Nutrition and Dietetics : the Official Journal of the British Dietetic Association|December 10, 2013
British Dietetic Association evidence-based guidelines for the dietary management of Crohn's disease in adultsJ Lee, R Allen, S Ashley, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 7, 2010
NF-κB links CO2 sensing to innate immunity and inflammation in mammalian cellsEoin P Cummins, Kathryn M Oliver, Colin R Lenihan, et al.
Pediatric Research|July 7, 2021
Carbon dioxide levels in neonates: what are safe parameters?Sie Kei Wong, M Chim, J Allen, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 23, 2006
Prolyl hydroxylase-1 negatively regulates IkappaB kinase-beta, giving insight into hypoxia-induced NFkappaB activityEoin P Cummins, Edurne Berra, Katrina M Comerford, et al.
Journal of Pharmaceutical and Biomedical Analysis|September 8, 2017
LC-MS/MS assay for the quantitation of the ribonucleotide reductase inhibitor triapine in human plasmaJulia Matsumoto, Brian F Kiesel, Robert A Parise, et al.
Frontiers in Immunology|February 8, 2017
NR4A Receptors Differentially Regulate NF-κB Signaling in Myeloid CellsCaitriona McEvoy, Monica de Gaetano, Hugh E Giffney, et al.
Leukemia & Lymphoma|April 6, 2011
Sunitinib in relapsed or refractory diffuse large B-cell lymphoma: a clinical and pharmacodynamic phase II multicenter study of the NCIC Clinical Trials GroupRena Buckstein, John Kuruvilla, Neil Chua, et al.
Pageof 30